Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza a (H1N1) virus

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1260-1265

  Doyle, William J ^a   Skoner, David P ^b   Alper, Cuneyt M ^b   Allen, Gregory ^b   Moody, Stephanie A ^b   Seroky, James T ^b   Hayden, Frederick G ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RIMANTADINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INFLUENZA; INFLUENZA VIRUS A; MALE; MUCOCILIARY CLEARANCE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRAIN DIFFERENCE; XEROSTOMIA;

EID: 0031925539     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515294     Document Type: Article

References (12)

1. Schappert SM. Office visits for otitis media: United States, 1975-1990. Atlanta: Centers for Disease Control, National Center for Health Statistics, 1991.
2. Bluestone CD, Klein JO. Otitis media in infants and children. Philadelphia: WB Saunders, 1988.
3. Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration and frequency of complications. Pediatrics 1991;87: 129-32.
4. Strangert K. Respiratory illness in preschool children with different forms of day care. Pediatrics 1976;57:191-6.
5. Wright PF, Thompson T, Karzon DT. Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol 1980;112:814-9.
6. Henderson FW, Collier AM, Sanyai MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982;306:1377-83.
7. Doyle WJ, Skoner DP, Hayden F, Buchman C, Seroky JT, Fireman P. Nasal and otologic effects of experimental influenza A virus infection. Ann Otol Rhinol Laryngol 1994;103:59-69.
8. Buchman CA, Doyle WJ, Skoner DP, et al. Influenza A virus-induced acute otitis media. J Infect Dis 1995;172:1348-51.
9. Wingfield WL, Pollak D, Grunert RR. Therapeutic efficacy of amantadine HCL and rimantadine HCL in naturally occurring influenza A2 respiratory illness in man. N Engl J Med 1969;281:579-84.
10. Rimantadine for prevention and treatment of influenza. Med Lett Drugs Ther 1993;35:109-10.
11. Hayden FG, Sperber SJ, Belshe RB, Clover RD, Hay AJ, Pyke S. Recovery of drug resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother 1991;35:1741-7.
12. Dowdle WR, Kendal AP, Noble GR. Influenza viruses. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral rickettsial and chlamydial infections. 5th ed. Washington, DC: American Public Health Association, 1979:585-609.